Medtronic Recalls Implantable Defibrillators

The FDA has issued a Class I recall of a Medtronic defibrillator with a potentially lethal malfunction due to a manufacturing defect.

Medtronic Evera / Image: Medtronic
Medtronic Evera / Image: Medtronic

A recent FDA Medical Device Safety report discussed the recall of two Medtronic devices due to a defect in the manufacturing process. A total of nine CRT-Ds and 12 ICD models were affected and included in the Class I recall issued by the FDA on Monday. Class I is the most serious type of recall and was assigned to these devices because the defect may prevent them from delivering life-saving electrical shock therapies.

The defect “causes an out of specification gas mixture inside the device and may prevent the device from delivering the electrical shock needed to pace a patient’s heartbeat or revive a patient in cardiac arrest,” the agency said. “The delay or inability to deliver a shock to a patient in cardiac arrest or pace a patient’s heart whose heartbeat is too slow could result in serious injury and/or death.”

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?